JP2020533002A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020533002A5 JP2020533002A5 JP2020514677A JP2020514677A JP2020533002A5 JP 2020533002 A5 JP2020533002 A5 JP 2020533002A5 JP 2020514677 A JP2020514677 A JP 2020514677A JP 2020514677 A JP2020514677 A JP 2020514677A JP 2020533002 A5 JP2020533002 A5 JP 2020533002A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- optionally
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762558230P | 2017-09-13 | 2017-09-13 | |
| US62/558,230 | 2017-09-13 | ||
| PCT/US2018/050955 WO2019055706A1 (en) | 2017-09-13 | 2018-09-13 | ANTI-MELANIN ANTIBODIES AND USES THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020533002A JP2020533002A (ja) | 2020-11-19 |
| JP2020533002A5 true JP2020533002A5 (https=) | 2021-10-21 |
Family
ID=65723127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020514677A Pending JP2020533002A (ja) | 2017-09-13 | 2018-09-13 | メラニン抗体及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11760791B2 (https=) |
| EP (1) | EP3681541A4 (https=) |
| JP (1) | JP2020533002A (https=) |
| KR (1) | KR20200044968A (https=) |
| CN (1) | CN111465414B (https=) |
| AU (1) | AU2018331430A1 (https=) |
| CA (1) | CA3074715A1 (https=) |
| IL (1) | IL273048A (https=) |
| WO (1) | WO2019055706A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA202191556A1 (ru) * | 2018-12-03 | 2021-10-14 | Фьюжн Фармасьютикалз Инк. | Комбинированная терапия радиоиммуноконъюгатами и ингибиторами контрольных точек |
| KR20220070116A (ko) | 2020-11-20 | 2022-05-30 | 주식회사 하울바이오 | 멜라닌 생성을 억제하는 항-티로시나아제 b8 항체 및 이의 용도 |
| KR20220112074A (ko) | 2021-02-03 | 2022-08-10 | 주식회사 세바바이오텍 | 멜라닌 생성 억제 효능을 갖는 항체가 함유된 비드 및 이의 용도 |
| CN119735674B (zh) * | 2024-12-06 | 2026-01-16 | 合肥综合性国家科学中心大健康研究院 | 抗vmat2的抗体或其抗原结合片段及其组合物和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7402385B2 (en) * | 2003-02-11 | 2008-07-22 | Albert Einstein College Of Medicine Of Yeshiva University | Radiolabeled antibodies for treatment of tumors |
| US20060039858A1 (en) | 2003-02-11 | 2006-02-23 | Ekaterina Dadachova | Radiolabeled antibodies and peptides for treatment of tumors |
| WO2010030325A1 (en) * | 2008-09-09 | 2010-03-18 | Albert Einstein College Of Medicine Of Yeshiva University | Methods for increasing efficacy of radioimmunotherapy of melanoma |
| SMT201700185T1 (it) | 2010-08-23 | 2017-05-08 | Univ Texas | Anticorpi anti-ox40 e metodi di uso degli stessi |
| LT2794658T (lt) * | 2011-12-19 | 2017-05-10 | Synimmune Gmbh | Bispecifinė antikūno molekulė |
| TWI716362B (zh) * | 2014-10-14 | 2021-01-21 | 瑞士商諾華公司 | 針對ｐｄ－ｌ１之抗體分子及其用途 |
-
2018
- 2018-09-13 JP JP2020514677A patent/JP2020533002A/ja active Pending
- 2018-09-13 CA CA3074715A patent/CA3074715A1/en active Pending
- 2018-09-13 WO PCT/US2018/050955 patent/WO2019055706A1/en not_active Ceased
- 2018-09-13 KR KR1020207010372A patent/KR20200044968A/ko not_active Ceased
- 2018-09-13 AU AU2018331430A patent/AU2018331430A1/en not_active Abandoned
- 2018-09-13 US US16/646,994 patent/US11760791B2/en active Active
- 2018-09-13 CN CN201880073136.1A patent/CN111465414B/zh not_active Expired - Fee Related
- 2018-09-13 EP EP18856150.0A patent/EP3681541A4/en not_active Withdrawn
-
2020
- 2020-03-04 IL IL273048A patent/IL273048A/en unknown